Restrictive transfusion practice is widely promoted, with many international guidelines recommending haemoglobin thresholds of 70 to 80 g/l for adult patients who are asymptomatic. Randomized controlled trials comparing outcomes associated with liberal and restrictive transfusion strategies underpin this approach. Meta-analyses including trials of adult patients >18 years of age have concluded that restrictive practice is noninferior to liberal transfusion approaches. A restrictive approach to transfusion reduces resource consumption and cost, as well as the hazards associated with unnecessary exposure to blood products. Although adults aged ≥65 years consume over half of the blood supply, there are few randomized controlled transfusion trials exclusive to this cohort. Our 2017 meta-analysis of a small number of trials focussed on older adults found that higher transfusion haemoglobin thresholds were associated with lower mortality and fewer cardiac complications in this age group. Other studies have also shown that higher transfusion haemoglobin thresholds are beneficial in older adults. This paper presents recent evidence regarding transfusion outcomes in older adults and discusses aspects of the pathophysiology of ageing that impact on the reduced resilience of older patients to anaemic states. This evidence challenges the use of Hb thresholds that apply across the adult lifespan, regardless of age. It proposes that older age be considered as a risk factor in assessing transfusion requirements, and that transfusion practice in older adults may require higher haemoglobin thresholds than for younger adults.
Introduction
The Transfusion Requirements in Critical Care (TRICC) trial [1] published in 1999 established a format for evaluating transfusion outcomes using different Hb thresholds to guide decision-making. Based on the finding of noninferiority of a restrictive (Hb 70 g/l) vs. liberal (Hb 100 g/l) approach to transfusion [1] , restrictive transfusion practice was promoted, as this approach reduces resource consumption and cost, and lessens the number of patients exposed to hazards associated with transfusion [2] . A range of patient blood management (PBM) guidelines have been published since 2012, and many recommend the use of a restrictive threshold of Hb 70 to 80 g/l in adult patients who are asymptomatic [3] . However, evidence is lacking for some patient subgroups including those with acute coronary syndromes, neoplastic and neurological disorders and long-term transfusion dependence [3] .
Studies conducted in various countries have identified that older adults consume >50% of the blood supply [4] [5] [6] . We recently undertook a systematic review and found Correspondence: Geoff Simon, University of the Sunshine Coast, School of Health and Sport Sciences, Health Tower (Building T), Locked Bag 4, Maroochydore, DC 4558, Australia E-mail: gsimon@usc.edu.au only three randomized controlled trials (RCT) comparing restrictive and liberal transfusion strategies in patients aged ≥65 years [7] , henceforth described as 'older adults'. It has been shown that both anaemia and transfusion may be associated with worse outcomes in this cohort [8] . Therefore, older adults require special consideration in terms of resource consumption, anaemia diagnosis and management, and for defining optimal transfusion practice.
Is there evidence to support higher haemoglobin thresholds?
Most meta-analyses do not consider age as a factor when analysing and interpreting results. Some meta-analyses of RCTs have identified adult patient groups that may benefit from liberal transfusion approaches. For example, a 2015 meta-analysis of 17 trials that examined subgroups of peri-operative and critically ill patients (n = 7552) found lower survival in the surgical group treated under a restrictive strategy (OR: 0Á81; 95% CI: 0Á66-1Á00; P = 0Á05) [9] . However, for critically ill patients, there was no difference between liberal and restrictive transfusion outcomes (OR: 1Á10; 95% CI: 0Á99-1Á23; P = 0Á07) [9] . The authors identified that their findings were at odds with a 2012 Cochrane Review [10] , but commented that the Cochrane Review meta-analysis was heavily weighted towards two studies that experienced a low level of enrolment of eligible patients, and hence may display some bias. A meta-analysis published in 2018 also compared critically ill and peri-operative patients (27 RCTs, n = 10 797) [11] . In surgical patients, they reported a trend towards lower mortality under a liberal strategy, although the results did not reach statistical significance (OR: 1Á31; 95% CI: 0Á94-1Á82, P = 0Á12) [11] . In critically ill patients, there was lower mortality under a restrictive transfusion strategy (OR: 0Á82; 95% CI: 0Á70-0Á97, P = 0Á019) [11] .
High-risk surgical and critically ill patients were examined in a 2016 meta-analysis of 31 RCTs for evidence of inadequate oxygen supply, mortality and infections associated with restrictive versus liberal transfusion strategies [12] . The study found that a restrictive strategy was associated with a greater risk of complications in elderly orthopaedic surgery patients and those undergoing cardiac and vascular surgery, but not in critically ill patients. The authors postulate that in patients demonstrating a low pre-existing oxygen reserve, increasing Hb has a protective effect, and reduces the likelihood of acidosis and organ failure due to oxygen supply dependency [12] . Another 2016 systematic review and meta-analysis of outcomes in patients with cardiovascular disease in noncardiac surgery settings (11 RCTs, n = 3033) identified a greater risk of acute coronary syndrome in patients managed using restrictive strategies (RR: 1Á78, 95% CI: 1Á18 to 2Á70, P = 0Á01) [13] .
The Transfusion Requirements in Critically Ill Oncological Patients (TRICOP) trial examining outcomes in 300 cancer patients with septic shock is one of the RCT reporting a survival trend in favour of liberal transfusion (59% vs. 70%; hazard ratio, 0Á72; 95% CI: 0Á53-0Á97; P = 0Á03) [8] . This outcome was contrary to the investigator's a priori hypothesis, as they expected to observe a reduction in risk associated with a restrictive transfusion approach [12] . The mean age (AE SD) of patients in the liberal and restrictive arms of this study were 61Á6 (AE 12Á9) and 61Á4 (AE 13Á5) years, respectively. Further examples of studies favouring higher transfusion Hb thresholds are discussed in a following section focussing on evidence in older adults.
Hence, there are a range of studies that support the use of higher Hb thresholds for transfusion. These findings are contrary to a recent update to a 2016 Cochrane Review including 37 trials and 19 049 patients, which established that restrictive transfusion thresholds of 70 to 80 g/l are safe for cardiac surgery patients [14] . The updated review reported no difference in 30-day mortality between restrictive and liberal transfusion groups [14] . Factors to consider when interpreting meta-analyses include that significant differences in methodology and heterogeneity of patient groups studied contribute to the apparent conflict in findings and their interpretation [11] , and many do not consider patient age as a variable.
Evidence specific to transfusion of older adults
We undertook a systematic review to identify transfusionrelated evidence in adults aged ≥65 years and reported the methodology and findings in 2017 [7] . As only three RCT were found that exclusively recruited patients aged ≥65 years, we included an additional six RCT revealed by the systematic review where the mean patient age was at least 64 years [7] . Among these nine RCTs subjected to meta-analysis, one reported on oncology surgery [15] , three on cardiac surgery [16] [17] [18] , and five on orthopaedic surgery [19] [20] [21] [22] [23] (n = 5780). A limitation of this review is that data is missing from studies that were not identified by the search strategy, and where analysis of study data by age was not available from primary studies. This is likely to have excluded studies where a significant proportion of patients were aged ≥65 years. The meta-analysis found that 30-day mortality (RR: 1Á36; 95% CI: 1Á05-1Á74, P = 0Á017, n = 4969), 90-day Number in cohort  88  134  38  93  108  39 M, male; F, female. Table 2 Peak cardiac output for adults aged ≤40 years, 41 to 60 years and >60 years [39] mortality (RR: 1Á45; 95% CI: 1Á05-1Á98, P = 0Á022, n = 2287) and cardiac outcomes (RR = 1Á62 95% CI: 1Á12-2Á35, P = 0Á010, n = 1367) favoured higher transfusion Hb thresholds across these nine RCTs [7] . When subgroup analysis of only the studies that recruited patients aged ≥65 years was performed, it showed a stronger bias towards higher Hb thresholds for 30-day mortality (RR: 2Á07, 95% CI: 1Á09-3Á92, P = 0Á03). In response to our article, other authors added seven studies containing older patients from a 2016 Cochrane Review [24] (which included all age groups except neonates) to our data set and repeated the meta-analysis [25] . No difference in mortality outcomes between liberal and restrictive strategies was found when the seven additional RCT including younger patients were added to the metaanalysis [25] . Hence, the mortality difference favouring higher transfusion Hb thresholds in adults ≥65 years is diminished when younger patients are included in the data set [26] . This demonstrates that the impact of transfusion may vary with age, highlighting the need for studies focussing on older adults, the largest blood using cohort.
Following publication of our meta-analysis, results from the Transfusion Requirements in Cardiac Surgery (TRICS III) RCT became available [27] . The TRICS III report provided summary composite outcomes (death, myocardial infarction, stroke or renal failure) for older adults, stratified by decade. The authors found that a restrictive strategy was noninferior to a liberal strategy in high-risk patients. Their subgroup analysis reported in favour of restrictive transfusion in the 75-to 84-year age group (OR: 0Á72, 95%CI: 0Á56-0Á94), but not in the 65 to 74 years (OR: 1Á03, 95%CI: 0Á76-1Á40) or 85 + years (OR: 0Á51, 95%CI: 0Á24-1Á08) age groups. Table 1 and Fig. 1 depict the restrictive and liberal transfusion thresholds for eight RCTs included in our meta-analysis, and in the TRICS III study. This comparison shows that there was appreciable variation in both restrictive (Hb range 70 to 97 g/l) and liberal (Hb range 85 to 113 g/l) thresholds applied across these studies. The liberal Hb threshold is a key difference between the RCTs included in our meta-analysis, which found lower mortality in liberal transfusion groups, and TRICS III, which found no difference between liberal and restrictive groups. The TRICS III liberal Hb threshold for hospitalized patients, excluding those in the ICU and operating room, was 85 g/l, which is lower than that of any of the studies included in our meta-analysis. It is also only 5 g/l higher than the restrictive threshold of five of the studies and below the restrictive threshold of another. For patients in the ICU or operating room, the TRICS III liberal threshold of 95 g/l was 5 g/l higher than two of the meta-analysis studies, but 5 g/l to 18 g/l below the remainder. At the liberal Hb thresholds used in the TRICS III trial, the peak oxygen delivery potential of older patients will be lower than for most trials included in our meta-analysis.
The Transfusion Indication Threshold Reduction (TITRe2) RCT included 2007 cardiac surgery patients with a median patient age of 69Á9 years in the restrictive (IQR: 63Á1-76Á0) and 70Á8 years (IQR: 64Á1-76Á7) in the liberal transfusion group [17] . Investigators found higher 90-day mortality under a restrictive compared to a liberal transfusion approach (4Á2% vs. 2Á6%; hazard ratio, 1Á64; 95% CI: 1Á00 to 2Á67; P = 0Á045) and concluded that a restrictive approach was not superior to a liberal strategy. TITRe2 has been the subject of a comprehensive Health Technology Assessment [28] which states that 'secondary findings create uncertainty about recommending restrictive transfusion and prompt a new hypothesis that liberal transfusion may be superior after cardiac surgery'.
A number of observational studies have also reported evidence of older age being a risk factor for transfusion. For example, a study examining the relationship between age and transfusion outcome for 9809 critically ill patients aged ≥18 years found no difference in 30-day or 1-year mortality when data were examined as a single cohort [29] . However, when patients who were transfused were stratified by age, patients aged ≤55 years had a higher mortality risk (OR: 1Á71, P < 0Á01), while those aged >75 years had reduced mortality (OR: 0Á70, P < 0Á01).
The 'ovseRvatoire des Infarctus de Côte d'Or' (RICO) study examined the association between transfusion and 1-year mortality outcomes in 3316 patients with acute myocardial infarction aged ≥65 years [30] . When the nadir Hb was below 80 g/l, transfusion was associated with a 50% reduction in mortality in patients aged ≥80 years (HR: 0Á43, 95%CI: 0Á22-0Á86, P = 0Á016), but this benefit was not observed in patients aged 65-79 years (HR: 1Á50, 95%CI: 0Á56-4Á01, P = 0Á424).
Most meta-analyses and reviews consider the adult population as a single cohort when evaluating outcomes associated with transfusion thresholds. Several of the studies discussed above underline the importance of considering age as well as severity of anaemia when considering transfusion thresholds [7, 8, 12, 17, 22, [28] [29] [30] . Poorer outcomes in older patients may be masked by better outcomes in younger patients when data is analysed cumulatively across the adult lifespan, and age is not considered as a variable.
To explore the negative implications of lower Hb levels in older adults, in a following section, we present a model of oxygen delivery at a range of ages and Hb levels. This model presents a plausible explanation for why patients in RCTs with higher liberal Hb thresholds were able to derive benefit from greater tissue oxygenation than those in restrictive groups, while those in the liberal arm of the TRICS III study did not have an advantage over the restrictive cohort.
Impacts of ageing relevant to transfusion
We hypothesize that older adults may be impacted differently by anaemia and the effects of transfusion than younger adults, and sought to investigate from a physiological perspective. Age-related pathophysiological changes affect organs and systems that are impacted by anaemia and transfusion. With advancing age, an accumulation of cellular and intracellular damage brings about levels of organ dysfunction that, under stress, may lead to organ and system failure [31] . Cardiac degeneration affects anatomic, histologic, physiologic and electrophysiologic performance [32, 33] . Autopsy studies find that 60% of people aged ≥60 years have at least one coronary artery that shows 75% or greater occlusion, however, only 20% of people aged ≥80 years show clinical signs of coronary artery disease [34] . These findings demonstrate the potential level of occult cardiac and vascular disease that may reduce the ability of older patients to cope with reductions in oxygen carrying capacity.
A combination of oxidative stress and immunosenescence-related changes drive a relationship between anaemia and physiological decline in older adults [31] . A range of factors contribute to a reduction in cardiac reserve and increased susceptibility to stress with age. These include changes in structural components, functional aspects, and protective and repair mechanisms [35] . Human evolution has resulted in a haematocrit range that balances oxygen delivery, blood viscosity and cardiac output under normal circumstances [36] . In the older adult, alterations in the microvasculature and blood-flow distribution conspire to limit whole-body arterial-venous oxygen delivery and extraction [37] . Thus, age-related trends exacerbate risk factors in older patients.
Dynamics of oxygen demand and delivery
While the Hb concentration provides information on the oxygen-carrying potential of blood, the result relates to conditions at a single point in time. Oxygen consumption (VO 2 ) however is not a static phenomenon, with the rate of oxygen delivery (DO 2 ) over time being critical to maintaining homoeostasis. Important contributors to DO 2 are the Hb-dependent oxygen concentration, pulmonary performance and cardiac output [38] . As older adults have a considerably lower capacity to increase cardiac output than younger adults [39] , they will be more sensitive to a reduction in Hb and be at greater risk of transitioning to anaerobic metabolism at lower Hb levels.
At rest, the ratio of DO 2 :VO 2 is maintained at approximately 4:1 to ensure adequate oxygen delivery for cellular metabolism [36, 40, 41] . An increase in energy demands will prompt a cardio-pulmonary response to increase oxygen intake and blood flow to support increased mitochondrial ATP synthesis within the cells [37] . At a DO 2 :VO 2 ratio of approximately 2:1, mitochondrial metabolism transitions from aerobic phosphorylation to anaerobic glycolysis [40] . Important consequences of this transition are a 15-fold decline in ATP production per mole of glucose, and the accumulation of lactate with an associated potential for acidosis, cellular death and organ failure [40, 41] . Hence, the capacity to maintain DO 2 at a sufficient multiple of VO 2 is a key to maintaining homoeostasis.
In an older adult with low reserves and impaired compensatory mechanisms, a state of oxygen supply deficiency leading to acidosis and organ failure may occur much more rapidly than in a younger patient [12] . The acute onset of oxygen supply dependency may be exacerbated by a rapid increase in VO 2 due to sepsis, inflammation or exercise [36] . When cardiac output is impacted by age-related changes or medications, raising the haemoglobin concentration is necessary to maintain DO 2 [36] .
Modelling oxygen delivery at different Hb levels and ages Using age-stratified mean peak cardiac output data from a study of healthy adults (n = 500) [39] (Table 2) , we have calculated potential DO 2 values at normal and anaemic Hb values (range 50 to 130 g/l) for adults aged 18-40 years, 41-60 years and >60 years (Table 3a , b). The following discussion is based on mean population values and calculations derived from this study. Our calculation of DO 2 potential makes the assumption that arterial oxygen saturation is 100%, and each gram of Hb is transporting 1Á34 ml of oxygen [42] . Figure 2a ,b plot the peak DO 2 values achievable at normal to anaemic Hb levels ranging from 130 to 50 g/l in males and females, respectively. The fall in peak DO 2 values observed with increasing age is a consequence of age-related reduction in cardiac output. The model predicts that, for any given Hb level, older adults will have a considerably lower peak DO 2 potential than either middle-aged or younger adults.
The Hb level of 70 g/l is a recommended restrictive transfusion threshold in several guidelines [2] . As indicated in Table 3a and Fig. 2a , at a Hb of 70 g/l, the younger adult male cohort will have a peak DO 2 potential of around 1600 ml/min. However, a male >60 years with a Hb of 70 g/l will only be able to deliver a peak of 1100 ml/min of oxygen. For the male >60 years to achieve a peak DO 2 of 1600 ml/min, they would require a Hb concentration close to 100 g/l (Table 3a , Fig. 2a) . Hence, the anaemic older male will experience the consequences of anaerobic metabolism much earlier than a young male under similar conditions of oxygen demand. Table 3b and Fig. 2b provide our modelling for younger and older females and indicate similar age-related differences.
It has been reported that an acute fall of Hb to around 50 g/l can be tolerated in healthy young adults at rest without an increase in plasma lactate [40] . Table 3a indicates that adult males <40 years have a peak DO 2 capacity of around 1100 ml/min at a Hb of 50 g/l. Males >60 years of age could only deliver around 800 ml/min of oxygen at this Hb level and are therefore more likely to transition to anaerobic metabolism. Our modelling indicates that males aged ≥60 years would need a Hb of close to 70 g/l to sustain the same peak DO 2 as young males with a Hb of 50 g/l. Thus, this modelling provides a physiological basis to explain experimental findings that older adults do better at higher Hb thresholds, while in younger adults, no mortality difference is seen between restrictive and liberal transfusion groups.
Conclusions
The variability in Hb thresholds across studies demonstrates that there is no consistent definition for restrictive or liberal transfusion, and this complicates the evaluation of whether older adults may benefit from higher Hb thresholds. The rationale for restrictive transfusion is to find the lowest Hb threshold that will minimize exposure to blood products, while not increasing the risk-benefit ratio towards greater harm. Evidence presented here indicates that restrictive transfusion guidelines should take patient age into account as a risk factor. Hence, instead of a restrictive threshold being applied across the adult lifespan, PBM principles would suggest that restrictive Hb thresholds should be age-specific. Future research should stratify patients by Hb levels and by age when investigating liberal versus restrictive transfusion practice.
Key challenges that lay ahead include determining whether age effects seen in studies are surrogates for an accumulation of co-morbidities in individuals or are widespread and predictable across populations; and determining at what age or ages transfusion guidance should be modified for the ageing population.
